secwatch / observer
8-K filed May 4, 2026, 7:59 PM ET ticker NHI CIK 0000877860
earnings confidence high sentiment negative materiality 0.80

NHI Q1 EPS +11% to $0.82 but cuts FY2026 FFO guidance to $4.74-$4.79

NATIONAL HEALTH INVESTORS INC

2026-Q1 EPS reported $0.82 revenue$115,130,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NATIONAL HEALTH INVESTORS INC reported the quarter ended March 31, 2026 results: EPS $0.82 per diluted share.

Period
the quarter ended March 31, 2026
EPS
$0.82 per diluted share
Result
reported results
Exact text from the filing
Net income attributable to common stockholders per diluted share for the quarter ended March 31, 2026 increased by 10.8% to $0.82 per share compared to $0.74 per share for the same period in the prior year.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NATIONAL HEALTH INVESTORS INC updated its 2026 full year guidance (lowered).

Period
2026 full year
Guidance
lowered
Result
guidance update
Exact text from the filing
NHI is updating its 2026 full year guidance range as follows: • NAREIT FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; • Normalized FFO per diluted share from a range of $4.94 - $4.99 to a range of $4.74 - $4.79; and • Normalized FAD from a range of $248.9 million - $251.4 million to a range of $240.6 million - $243.7 million.
View on SEC.gov

1427 earnings releases filed in the last 30 days. Browse all earnings releases →

NATIONAL HEALTH INVESTORS INC filing history →

Source: SEC EDGAR
accession 0000877860-26-000136
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.